187 related articles for article (PubMed ID: 24686018)
1. Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
Wang N; Świtalska M; Wu MY; Imai K; Ngoc TA; Pang CQ; Wang L; Wietrzyk J; Inokuchi T
Eur J Med Chem; 2014 May; 78():314-23. PubMed ID: 24686018
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.
Lu CM; Chen YL; Chen HL; Chen CA; Lu PJ; Yang CN; Tzeng CC
Bioorg Med Chem; 2010 Mar; 18(5):1948-57. PubMed ID: 20171108
[TBL] [Abstract][Full Text] [Related]
4. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted chromeno[2,3-b]indoles.
Peng W; Świtalska M; Wang L; Mei ZW; Edazawa Y; Pang CQ; El-Tantawy El-Sayed I; Wietrzyk J; Inokuchi T
Eur J Med Chem; 2012 Dec; 58():441-51. PubMed ID: 23151321
[TBL] [Abstract][Full Text] [Related]
6. Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
Sidoryk K; Jaromin A; Edward JA; Świtalska M; Stefańska J; Cmoch P; Zagrodzka J; Szczepek W; Peczyńska-Czoch W; Wietrzyk J; Kozubek A; Zarnowski R; Andes DR; Kaczmarek Ł
Eur J Med Chem; 2014 May; 78():304-13. PubMed ID: 24686017
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer evaluation of certain indolo[2,3-b]quinoline derivatives.
Chen YL; Hung HM; Lu CM; Li KC; Tzeng CC
Bioorg Med Chem; 2004 Dec; 12(24):6539-46. PubMed ID: 15556770
[TBL] [Abstract][Full Text] [Related]
8. SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.
Badowska-Rosłonek K; Ciesielska A; Switalska M; Piskozub M; Peczyńska-Czoch W; Wietrzyk J; Kaczmarek Ł
Acta Pol Pharm; 2016; 73(3):683-92. PubMed ID: 27476287
[TBL] [Abstract][Full Text] [Related]
9. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
[TBL] [Abstract][Full Text] [Related]
10. The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents.
Sidoryk K; Świtalska M; Jaromin A; Cmoch P; Bujak I; Kaczmarska M; Wietrzyk J; Dominguez EG; Żarnowski R; Andes DR; Bańkowski K; Cybulski M; Kaczmarek Ł
Eur J Med Chem; 2015 Nov; 105():208-19. PubMed ID: 26496013
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, β-haematin inhibition, and in vitro antimalarial testing of isocryptolepine analogues: SAR study of indolo[3,2-c]quinolines with various substituents at C2, C6, and N11.
Wang N; Wicht KJ; Imai K; Wang MQ; Anh Ngoc T; Kiguchi R; Kaiser M; Egan TJ; Inokuchi T
Bioorg Med Chem; 2014 May; 22(9):2629-42. PubMed ID: 24721829
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and In Vitro Antiproliferative Activity of 11-Substituted Neocryptolepines with a Branched ω-Aminoalkylamino Chain.
Shaban E; Świtalska M; Wang L; Wang N; Xiu F; Hayashi I; Ngoc TA; Nagae S; El-Ghlban S; Shimoda S; Gokha AAAE; Sayed IETE; Wietrzyk J; Inokuchi T
Molecules; 2017 Nov; 22(11):. PubMed ID: 29137152
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
Helissey P; Cros S; Giorgi-Renault S
Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumoral activity of novel thiazolobenzotriazole, thiazoloindolo[3,2-c]quinoline and quinolinoquinoline derivatives.
Beauchard A; Jaunet A; Murillo L; Baldeyrou B; Lansiaux A; Chérouvrier JR; Domon L; Picot L; Bailly C; Besson T; Thiéry V
Eur J Med Chem; 2009 Oct; 44(10):3858-65. PubMed ID: 19427714
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimalarial testing of neocryptolepine analogues: addition of ester function in SAR study of 2,11-disubstituted indolo[2,3-b]quinolines.
Lu WJ; Wicht KJ; Wang L; Imai K; Mei ZW; Kaiser M; El Sayed Iel T; Egan TJ; Inokuchi T
Eur J Med Chem; 2013 Jun; 64():498-511. PubMed ID: 23685569
[TBL] [Abstract][Full Text] [Related]
18. Indolo[3,2-c]quinoline G-quadruplex stabilizers: a structural analysis of binding to the human telomeric G-quadruplex.
Lavrado J; Ohnmacht SA; Correia I; Leitão C; Pisco S; Gunaratnam M; Moreira R; Neidle S; Santos DJ; Paulo A
ChemMedChem; 2015 May; 10(5):836-49. PubMed ID: 25820698
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines.
Dzieduszycka M; Bontemps-Gracz MM; Stefańska B; Martelli S; Piwkowska A; Arciemiuk M; Borowski E
Bioorg Med Chem; 2006 May; 14(9):2880-6. PubMed ID: 16458007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
